Company · CIK 0001810560 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
REVELATION BIOSCIENCES, INC. · REVB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 AForm 4 → | Aug 18, 5:00 pm EDT | James RolkeChief Executive Officer, Director | 208,076 | — | — | 422,814 | — | |
| Aug 17, 2026 AForm 4 → | Aug 18, 5:00 pm EDT | Lakhmir S ChawlaDirector | 32,011 | — | — | 44,169 | — | |
| Aug 17, 2026 AGForm 4 → | Aug 18, 5:00 pm EDT | Chester Stanley Zygmont IIIChief Financial Officer | 624,219 | — | — | 300,136 | — | |
| Aug 17, 2026 AForm 4 → | Aug 18, 5:00 pm EDT | Jess RoperDirector | 32,011 | — | — | 44,839 | — | |
| Aug 17, 2026 AForm 4 → | Aug 18, 5:00 pm EDT | Jennifer CarverDirector | 32,011 | — | — | 44,769 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.